Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 45 049,99 ₴, with a 24-hour trading volume of 91,15B ₴. The asset's market cap is 40,17T ₴, after moving -0.25% in the last day.
Tokenized Eli Lilly And Co is trading at 45 220,89 ₴, with a tokenized market cap of 255,41M ₴ and a 24-hour trading volume of 91,63M ₴. The tokenized asset has moved 0.71% in the past 24 hours.